Role Faculty Location Zuckerberg San Francisco General Hospital Category Clinical Education Ph.D., 1994 - Biochemistry & Biophysics, University of CaliforniaB.A., 1990 - Molecular Biology, Princeton University Publications A phase 1b dose escalation study of FOR46, a novel antibody-drug conjugate targeting a tumor-specific epitope of CD46, in combination with enzalutamide (Enza) in patients with metastatic castration resistant prostate cancer (mCRPC) Nonna Shakhnazaryan, Nathan Curry, Medini Rastogi, Daniel Avins, Shrina Pandey, Ivan de Kouchkovsky, Daniel Kwon, Arpita Desai, Kelly N. Fitzgerald, Rohit Bose, Jonathan Chou, Terence W. Friedlander, Vadim S Koshkin, Lawrence Fong, Maya Aslam, Khadija Siddiqua, Eric J. Small, Bin Liu, Robert R. Flavell, Rahul Raj Aggarwal. Development of CD46 Targeted Alpha Theranostics in Prostate Cancer using134Ce/225Ac-Macropa-PEG4-YS5 Kondapa Naidu Bobba, Anil P. Bidkar, Anju Wadhwa, Niranjan Meher, Suchi Drona, Alexandre M. Sorlin, Scott Bidlingmaier, Li Zhang, David M. Wilson, Emily Chan, Nancy Y. Greenland, Rahul Aggarwal, Henry F. VanBrocklin, Jiang He, Jonathan Chou, Youngho Seo, Bin Liu, Robert R. Flavell. CD46-targeted theranostics for Positron Emission Tomography and 225Ac-radiopharmaceutical Therapy of Multiple Myeloma Anju Wadhwa, Sinan Wang, Bonell Patino Escobar, Anil P. Bidkar, Kondapa Naidu Bobba, Emily Chan, Niranjan Meher, Scott Bidlingmaier, Yang Su, Suchi Drona, Huimin Geng, Vishesh Sarin, Henry F. VanBrocklin, David M. Wilson, Jiang He, Li Zhang, Veronica Steri, Sandy Wong, Tom Martin, Youngho Seo, Bin Liu, Arun P. Wiita, Robert R. Flavell. 2023 Dec 18. PMID: 38109209 PMCID: PMC10905524. doi: 10.1158/1078-0432.CCR-23-2130. CD46-ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts Michael J. VanWyngarden, Zachary J. Walker, Yang Su, Olivia Perez de Acha, Brett M. Stevens, Peter A. Forsberg, Tomer M. Mark, William Matsui, Bin Liu*, Daniel W. Sherbenou*. (*co-senior authors) CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment Jun Li, Tao Huang, Jun Hua, Qiong Wang, Yang Su, Ping Chen, Scott Bidlingmaier, Allan Li, Zhongqiu Xie, Anil Bidkar, Sui Shen, Weibin Shi, Youngho Seo, Robert R. Flavell, Daniel Gioeli, Robert Dreicer, Hui Li, Bin Liu*, Jiang He*. (*co-senior authors) Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225 Ac a-Radiotherapeutics Kondapa Naidu Bobba, Anil P Bidkar, Niranjan Meher, Cyril Fong, Anju Wadhwa, Suchi Dhrona, Alex Sorlin, Scott Bidlingmaier, Becka Shuere, Jiang He, David M. Wilson, Bin Liu, Youngho Seo, Henry F. VanBrocklin, Robert R. Flavell. Modular Design of Synthetic Receptors for Programmed Gene Regulation in Cell Therapies Zhu, I., Liu, R., Garcia, J.M., Hyrenius-Wittsten, A., Piraner, D., Alavi, J., Israni, D.V., Liu, B., Khalil, A.S., Roybal, K.T. Phase 1a/1b study of FOR46, an antibody drug conjugate (ADC), targeting CD46 in metastatic castration-resistant prostate cancer (mCRPC) Aggarwal, R.R., Vuky, J., VanderWeele, D.J., Rettig, M., Heath, E.I., Beer, T.M., Huang, J., Pawlowska, N., Sinit, R., Abbey, J., Liu, B., Nasoff, M., Dorr, A., Small, E.J. Phase 1a/1b study of FOR46, an antibody drug conjugate (ADC), targeting CD46 in metastatic castration-resistant prostate cancer (mCRPC) Aggarwal, R.R., Vuky, J., VanderWeele, D.J., Rettig, M., Heath, E.I., Beer, T.M., Huang, J., Pawlowska, N., Sinit, R., Abbey, J., Liu, B., Nasoff, M., Dorr, A., Small, E.J. Enhanced Solid Tumor Recognition and T cell Stemness with SynNotch CAR Circuits Hyrenius-Wittsten, A., Su, Y., Park, M., Garcia, J.M., Perry, N., Montgomery, G., Liu, B*., Roybal, K.T* A first-in-human study of FOR46 in men with metastatic castration resistant prostate cancer (mCRPC) R.R. Aggarwal, J. Vuky, D. VanderWeele, M. Rettig, E. Heath, M. Nasoff, A. Dorr, B. Liu, E.J. Small. Molecular imaging of prostate cancer targeting CD46 using immunoPET Wang, S., Li, J., Hua, J., Su, Y., Beckford-Vera, D., Zhao, W., Jayaraman, M., Huynh, T.L., Zhao, N., Wang, Y.H., Huang, Y., Qin, F., Shen, S., Gioeli, D., Dreicer, R., Sriram, R., Egusa, E.A., Chou, J., Feng, F., Aggarwal, R., Evans, M.J., Seo, Y., Liu, B.*, Flavell, R.R.*, He, J.* Potent activity of an anti-ICAM1 antibody-drug conjugate against multiple myeloma Sherbenou, D.W., Su, Y., Behrens, C.R., Aftab, B.T., Perez de Acha, O., Murnane, M., Bearrows, S.C., Hann, B.C., Wolf, J.L., Martin, T.G., and Liu, B. ALPPL2 is a highly specific and targetable tumor cell surface antigen Su, Y., Zhang, X., Bidlingmaier, S., Behrens, C.R., Lee, N.K., and Liu, B. Quantitative (99m)Tc Labeling Kit for HYNIC-Conjugated Single Chain Antibody Fragments Targeting Malignant Mesothelioma He, J., Feng, J., Su, Y., Seo, Y., and Liu, B. LegoBody: facile generation of bispecific and multi-specific antibodies Lang, S., Yang, S., Bidlingmaier, S., Lee, N-K., Liu, B. Manipulation of cell-type selective antibody internalization by a guide-effector bispecific design Lee, N.K., Su, Y., Bidlingmaier, S., and Liu, B. Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer Su, Y., Liu, Y., Behrens, C.R., Bidlingmaier, S., Lee, N.K., Aggarwal, R., Sherbenou, D.W., Burlingame, A.L., Hann, B.C., Simko, J.P., Premasekharan, G., Paris, P.L., Shuman, M.A., Seo, Y., Small, E.J., and Liu, B. Cell-type specific potent Wnt signaling blockade by bispecific antibody Lee, N.K., Zhang, Y., Su, Y., Bidlingmaier, S., Sherbenou, D.W., Ha, K.D., Liu, B. Combine Phage Antibody Display Library Selection on Patient Tissue Specimens with Laser Capture Microdissection to Identify Novel Human Antibodies Targeting Clinically Relevant Tumor Antigens Su, Y., Bidlingmaier, S., Lee, N.K., Liu, B. Modular Construction of Large Non-Immune Human Antibody Phage-Display Libraries from Variable Heavy and Light Chain Gene Cassettes Lee, N.K., Bidlingmaier, S., Su, Y., Liu, B. Identification of Novel Macropinocytosing Human Antibodies by Phage Display and High-Content Analysis Ha, K., Bidlingmaier, S., Su, Y., Lee, N.K., Liu, B. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells Sherbenou, D.W., Aftab, B.T., Su, Y., Behrens, C.R., Wiita, A., Logan, A.C., Acosta-Alvear, D., Hann, B.C., Walter, P., Shuman, M.A., Wu, X., Atkinson, J.P., Wolf, J.L., Martin, T.G., Liu, B. Proteome-wide identification of novel ceramide-binding proteins by yeast surface cDNA display and deep sequencing Bidlingmaier, S., Ha, K., Lee, N.K., Su, Y., Liu, B. Macropinocytosis exploitation by cancers and cancer therapy Ha, K., Bidlingmaier, S., Su, Y., Lee, N.K., Liu, B. Combining phage and yeast cell surface antibody display to identify novel cell type-selective internalizing human monoclonal antibodies Bidlingmaier, S., Liu, B. Identification of Posttranslational Modification-Dependent Protein Interactions Using Yeast Surface Displayed Human Proteome Libraries Bidlingmaier, S., Su, Y., and Liu, B. Identification of novel protein-ligand interactions by exon microarray analysis of yeast surface displayed cDNA library selection outputs Bidlingmaier, S., Liu, B. The Development of Potential Antibody-Based Therapies for Multiple Myeloma Sherbenou, D.W., Behrens, C.R. Yang Su, Wolf, J.L., Martin III, T.G., and Liu, B. Utilizing Yeast Surface Human Proteome Display Libraries to Identify Small Molecule-Protein Interactions Bidlingmaier, S. and Liu, B. Methods for site-specific drug conjugation to antibodies. Behrens CR, Liu B Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor. Federman N, Chan J, Nagy JO, Landaw EM, McCabe K, Wu AM, Triche T, Kang H, Liu B, Marks JD, Denny CT An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors. McCabe KE, Liu B, Marks JD, Tomlinson JS, Wu H, Wu AM Novel human single chain antibody fragments that are rapidly internalizing effectively target epithelioid and sarcomatoid mesotheliomas. Iyer AK, Lan X, Zhu X, Su Y, Feng J, Zhang X, Gao D, Seo Y, Vanbrocklin HF, Broaddus VC, Liu B, He J The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma. Iyer AK, Su Y, Feng J, Lan X, Zhu X, Liu Y, Gao D, Seo Y, Vanbrocklin HF, Courtney Broaddus V, Liu B, He J Construction of yeast surface-displayed cDNA libraries. Bidlingmaier S, Liu B Identification of protein/target molecule interactions using yeast surface-displayed cDNA libraries. Bidlingmaier S, Liu B Comprehensive analysis of yeast surface displayed cDNA library selection outputs by exon microarray to identify novel protein-ligand interactions. Bidlingmaier S, Wang Y, Liu Y, Zhang N, Liu B Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Chen Y, Zhu X, Zhang X, Liu B, Huang L Identification of internalizing human single antibodies targeting brain tumor stem cells Zhu, X., Bidlingmaier, S., Hashizume, R., James, C.D., Berger, M.S., and Liu, B. Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single chain antibody fragment He, J., Wang, Y., Feng, J., Zhu, J., Lan, X., Iyer, A.K., Zhang, N., Seo, Y., VanBrocklin, H.F., and Liu, B. Development of a highly stable and targetable nanoliposomal formulation of topotecan. Drummond DC, Noble CO, Guo Z, Hayes ME, Connolly-Ingram C, Gabriel BS, Hann B, Liu B, Park JW, Hong K, Benz CC, Marks JD, Kirpotin DB Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, Gao D, Franc B, Broaddus VC, Liu B Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion Conrad, F., Zhu, X., Zhang, X., Chalkley, R.J., Burlingame, A.L., Marks, J.D., and Liu, B. Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single chain antibodies An, F., Drummond, D.C., Wilson, S., Kirpotin, D.B., Nishimura, S., Broaddus, C.V. and Liu, B. The utility and limitation of CD133 epitopes in defining tumor stem cell population Bidlingmaier, S., Zhu, X., and Liu, B. Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies. Goenaga AL, Zhou Y, Legay C, Bougherara H, Huang L, Liu B, Drummond DC, Kirpotin DB, Auclair C, Marks JD, Poul MA Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells Roth, A, Conrad, F., Hayes, M., Drummond, D.C., Kirpotin, D.B., Benz, C.C., Marks, J.D., and Liu, B. Explore Cell Type-Specific Internalizing Antibodies For Targeted siRNA Delivery Liu, B. Interrogating yeast surface-displayed human proteome to identify small molecule-binding proteins Bidlingmaier, S and Liu, B. Prostate cancer targeting recombinant human IgG1s Liu, B., Conrad, F., Roth, A., Drummond, D.C and Marks, J.D. Construction and application of a yeast surface-displayed human cDNA library to identify post-translational modification-dependent protein-protein interactions Bidlingmaier, S. and Liu, B. Identification of clinically significant tumor antigens by selecting phage antibody library on tumor cells in situ using laser capture microdissection Ruan, W., Sassoon, A., An, F., Simko, J.P., Liu, B. Mapping tumor epitope space by direct selection of single chain Fv antibody libraries on prostate cancer cells Liu, B., Conrad, F., Cooperberg, M.R., Kirpotin, D.B., Marks, J.D. Towards proteome-wide production of monoclonal antibody by phage display Liu, B., Huang, L., Burlingame, A.L., Marks, J.D. Applying phage antibodies to proteomics: selecting single chain Fv antibodies to antigens blotted on nitrocellulose. Liu B, Marks JD Head-on collision between a DNA replication apparatus and RNA polymerase transcription complex. Liu B, Alberts BM Organizational change as human process, not technique. Diamond MA A transcribing RNA polymerase molecule survives DNA replication without aborting its growing RNA chain. Liu B, Wong ML, Alberts B The DNA replication fork can pass RNA polymerase without displacing the nascent transcript. Liu B, Wong ML, Tinker RL, Geiduschek EP, Alberts BM
